Pegdwende Olivia Dialla1, Wai-On Chu1, Patrick Roignot2, Marie-Christine Bone-Lepinoy3, Marie-Laure Poillot1, Charles Coutant4, Patrick Arveux1, Tienhan Sandrine Dabakuyo-Yonli5. 1. Breast and Gynaecologic Cancer Registry of Côte d'Or, Centre Georges François Leclerc Comprehensive Cancer Centre, 1 rue Professeur Marion BP 77980, 21079 Dijon Cedex, France; EA 4184, Faculty of Medicine, University of Burgundy, Dijon, France. 2. Pathology Centre, 33 rue Nicolas Bornier, 21000 Dijon, France. 3. Centre Radiotherapie du Parc, 18 cours du General de Gaulle, 21000 Dijon Cedex, France. 4. Department of Surgical Oncology, Centre Georges François Leclerc Comprehensive Cancer Centre, 1 rue Professeur Marion BP 77980, 21079 Dijon Cedex, France. 5. EA 4184, Faculty of Medicine, University of Burgundy, Dijon, France; Biostatistics and Quality of Life Unit, Centre Georges François Leclerc Comprehensive Cancer Centre, 1 rue Professeur Marion BP 77980, 21079 Dijon Cedex, France; National Quality of Life in Oncology Platform, France. Electronic address: sdabakuyo@cgfl.fr.
Abstract
OBJECTIVES: The main purpose of this study was to identify age-related socioeconomic and clinical determinants of quality of life among breast cancer survivors five years after the diagnosis. The secondary objective was to describe quality of life in the studied population according to age. STUDY DESIGN: A cross-sectional survey in five-year breast cancer survivors was conducted in women diagnosed with breast cancer in 2007 and 2008 in Côte d'Or. MAIN OUTCOME MEASURES: Quality of life was assessed with the SF-12, the EORTC-QLQ-C30 and the EORTC-QLQ-BR23 questionnaires. Socio-economic deprivation was assessed by the EPICES questionnaire. Social support was assessed by the Sarason questionnaire and clinical features were collected through the Côte d'Or breast cancer registry. Age-related determinants of quality of life were identified using multivariate mixed model analysis for each SF-12 dimension. RESULTS: Overall 396 women completed the questionnaires. Women aged <65 years had a better quality of life and a greater availability of social support than did women aged ≥65 years. Body mass index, relapse and EPICES were found to be determinants of quality of life in younger women (p<0.006). For older women, comorbidities and EPICES deprivation scores were predictors of low quality of life scores (p<0.006). CONCLUSIONS: Five years after breast cancer diagnosis, disease severity did not affect quality of life. The major determinants of quality of life in younger women were disease relapse and EPICES deprivation scores while those in older women were comorbidities and EPICES deprivation scores.
OBJECTIVES: The main purpose of this study was to identify age-related socioeconomic and clinical determinants of quality of life among breast cancer survivors five years after the diagnosis. The secondary objective was to describe quality of life in the studied population according to age. STUDY DESIGN: A cross-sectional survey in five-year breast cancer survivors was conducted in women diagnosed with breast cancer in 2007 and 2008 in Côte d'Or. MAIN OUTCOME MEASURES: Quality of life was assessed with the SF-12, the EORTC-QLQ-C30 and the EORTC-QLQ-BR23 questionnaires. Socio-economic deprivation was assessed by the EPICES questionnaire. Social support was assessed by the Sarason questionnaire and clinical features were collected through the Côte d'Or breast cancer registry. Age-related determinants of quality of life were identified using multivariate mixed model analysis for each SF-12 dimension. RESULTS: Overall 396 women completed the questionnaires. Women aged <65 years had a better quality of life and a greater availability of social support than did women aged ≥65 years. Body mass index, relapse and EPICES were found to be determinants of quality of life in younger women (p<0.006). For older women, comorbidities and EPICES deprivation scores were predictors of low quality of life scores (p<0.006). CONCLUSIONS: Five years after breast cancer diagnosis, disease severity did not affect quality of life. The major determinants of quality of life in younger women were disease relapse and EPICES deprivation scores while those in older women were comorbidities and EPICES deprivation scores.
Authors: J Masià; Á Merchán-Galvis; K Salas; C Requeijo; E Cánovas; M J Quintana; X Bonfill Journal: Clin Transl Oncol Date: 2019-07-20 Impact factor: 3.405
Authors: Ana Isabel Cobo-Cuenca; Noelia María Martín-Espinosa; María Aurora Rodríguez-Borrego; Juan Manuel Carmona-Torres Journal: Qual Life Res Date: 2018-10-15 Impact factor: 4.147
Authors: Daniela Doege; Melissa S Y Thong; Lena Koch-Gallenkamp; Heike Bertram; Andrea Eberle; Bernd Holleczek; Alice Nennecke; Ron Pritzkuleit; Annika Waldmann; Sylke R Zeissig; Hermann Brenner; Volker Arndt Journal: J Cancer Res Clin Oncol Date: 2022-07-25 Impact factor: 4.322
Authors: Jihye Park; Juan L Rodriguez; Katie M O'Brien; Hazel B Nichols; M Elizabeth Hodgson; Clarice R Weinberg; Dale P Sandler Journal: Cancer Date: 2020-11-25 Impact factor: 6.921
Authors: Jéssica Alonso-Molero; Trinidad Dierssen-Sotos; Ines Gomez-Acebo; Nerea Fernandez de Larrea Baz; Marcela Guevara; Pilar Amiano; Gemma Castaño-Vinyals; Tania Fernandez-Villa; Victor Moreno; Juan Bayo; Ana Molina-Barceloa; María Fernández-Ortíz; Claudia Suarez-Calleja; Rafael Marcos-Gragera; Xavier Castells; Leire Gil-Majuelo; Eva Ardanaz; Beatriz Pérez-Gómez; Manolis Kogevinas; Marina Pollán; Javier Llorca Journal: Int J Environ Res Public Health Date: 2020-11-13 Impact factor: 3.390